✦ LIBER ✦
Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial
✍ Scribed by Hillel Panitch; Douglas Goodin; Gordon Francis; Peter Chang; Patricia Coyle; Paul O'Connor; David Li; Brian Weinshenker
- Book ID
- 119301795
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 153 KB
- Volume
- 239
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.